CIK 0001817713
- Large accelerated filer
Janux Therapeutics, Inc.
Sign in to watch- Ticker
- JANX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 822289112
- Phone
- +1 858-751-4493
- Business address
- 10955 VISTA SORRENTO PARKWAY, SUITE 200, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 38 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-10-17 | Avalon Ventures XI, L.P. 10% owner | Option exercise · Stock Option (right to buy) | −348 | 9,142 | ||
| 2024-10-17 | Avalon Ventures XI, L.P. 10% owner | Option exercise · Stock Option (right to buy) | −237 | 6,072 | ||
| 2024-10-16 | Avalon Ventures XI, L.P. 10% owner | Sale | −60,179 | $49.69 | $3.0M | 2,761,291 |
| 2024-10-16 | Avalon Ventures XI, L.P. 10% owner | Sale | −11,657 | $49.69 | $579K | 534,883 |
| 2024-10-16 | Avalon Ventures XI, L.P. 10% owner | Sale | −61,445 | $49.69 | $3.1M | 2,819,366 |
| 2024-10-16 | Avalon Ventures XI, L.P. 10% owner | Sale | −29,474 | $50.61 | $1.5M | 2,731,817 |
| 2024-10-16 | Avalon Ventures XI, L.P. 10% owner | Sale | −5,710 | $50.61 | $289K | 529,173 |
| 2024-10-16 | Avalon Ventures XI, L.P. 10% owner | Sale | −30,094 | $50.61 | $1.5M | 2,789,272 |
| 2024-10-16 | Avalon Ventures XI, L.P. 10% owner | Option exercise | +4,968 | $17.00 | $84K | 11,855 |
| 2024-10-16 | Avalon Ventures XI, L.P. 10% owner | Option exercise | +2,070 | $10.73 | $22K | 13,925 |
| 2024-10-16 | Avalon Ventures XI, L.P. 10% owner | Option exercise | +2,070 | $13.22 | $27K | 15,995 |
| 2024-10-16 | Avalon Ventures XI, L.P. 10% owner | Option exercise | +1,407 | $39.80 | $56K | 17,402 |
| 2024-10-16 | Avalon Ventures XI, L.P. 10% owner | Sale | −10,957 | $50.80 | $557K | 6,445 |
| 2024-10-16 | Avalon Ventures XI, L.P. 10% owner | Option exercise · Stock Option (right to buy) | −4,968 | 22,776 | ||
| 2024-10-16 | Avalon Ventures XI, L.P. 10% owner | Option exercise · Stock Option (right to buy) | −2,070 | 9,490 | ||
| 2024-10-16 | Avalon Ventures XI, L.P. 10% owner | Option exercise · Stock Option (right to buy) | −2,070 | 9,490 | ||
| 2024-10-16 | Avalon Ventures XI, L.P. 10% owner | Option exercise · Stock Option (right to buy) | −1,407 | 6,309 | ||
| 2024-09-30 | Avalon Ventures XI, L.P. 10% owner | Option exercise | +434 | $17.00 | $7K | 7,360 |
| 2024-09-30 | Avalon Ventures XI, L.P. 10% owner | Option exercise | +181 | $10.73 | $2K | 7,541 |
| 2024-09-30 | Avalon Ventures XI, L.P. 10% owner | Option exercise | +181 | $13.22 | $2K | 7,722 |
Page 8 of 15 · 294 trades